Please login to the form below

Not currently logged in
Email:
Password:

Zejula

This page shows the latest Zejula news and features for those working in and with pharma, biotech and healthcare.

NICE recommends GSK’s Zejula for patients with ovarian cancer

NICE recommends GSK’s Zejula for patients with ovarian cancer

GlaxoSmithKline (GSK) has announced that the National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination (FAD) recommending the use of Zejula (niraparib) on the NHS. ... Zejula is recommended as a therapy option

Latest news

More from news
Approximately 9 fully matching, plus 39 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Viseven

Viseven is a Global MarTech Services Provider for Pharma and Life Sciences Industries...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...